Diabetes drives increase in fatty liver, higher risk for fibrosis in the US

Diabetes drives increase in fatty liver, higher risk for fibrosis in the US

Prevalence of fatty liver in the United States increased significantly between 1999 and 2016 with high- and moderate-risk groups also growing, according to a presentation at Digestive Diseases Week.“This is an important study to inform policy makers what is it that we are going to deal with in fatty liver disease in the future, so we address treatment strategies and algorithms to identify these patients in the general population and connect and link them to appropriate care,” Zobair Younossi, MD, told Healio. “In 2016, about 38% of patients with fatty liver disease, which isRead More

Share on facebook
Share on twitter
Share on linkedin